Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 345

Similar articles for PubMed (Select 20153776)

1.

Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice.

Prabakaran M, Madhan S, Prabhu N, Geng GY, New R, Kwang J.

Antiviral Res. 2010 May;86(2):180-7. doi: 10.1016/j.antiviral.2010.02.315. Epub 2010 Feb 12.

PMID:
20153776
2.

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.

Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.

Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002. Epub 2008 Sep 10.

3.

Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection.

Prabakaran M, Madhan S, Prabhu N, Qiang J, Kwang J.

J Virol. 2010 Apr;84(7):3201-9. doi: 10.1128/JVI.02175-09. Epub 2010 Jan 13.

4.

Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge.

Prabakaran M, Kolpe AB, He F, Kwang J.

Vaccine. 2013 Feb 27;31(10):1385-92. doi: 10.1016/j.vaccine.2013.01.003. Epub 2013 Jan 14.

PMID:
23328313
5.

Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection.

Asahi-Ozaki Y, Itamura S, Ichinohe T, Strong P, Tamura S, Takahashi H, Sawa H, Moriyama M, Tashiro M, Sata T, Kurata T, Hasegawa H.

Microbes Infect. 2006 Oct;8(12-13):2706-14. Epub 2006 Aug 28.

PMID:
16968669
6.

Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.

Isaka M, Zhao Y, Nobusawa E, Nakajima S, Nakajima K, Yasuda Y, Matsui H, Hasegawa T, Maeyama J, Morokuma K, Ohkuma K, Tochikubo K.

Microbiol Immunol. 2008 Feb;52(2):55-63. doi: 10.1111/j.1348-0421.2008.00010.x.

PMID:
18380802
7.

Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.

Harada Y, Ninomiya-Mori A, Takahashi Y, Shirakura M, Kishida N, Kageyama T, Tada Y, Tashiro M, Odagiri T.

Vaccine. 2011 Oct 26;29(46):8330-7. doi: 10.1016/j.vaccine.2011.08.091. Epub 2011 Sep 10.

PMID:
21911027
8.

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

Mahmood K, Bright RA, Mytle N, Carter DM, Crevar CJ, Achenbach JE, Heaton PM, Tumpey TM, Ross TM.

Vaccine. 2008 Oct 3;26(42):5393-9. doi: 10.1016/j.vaccine.2008.07.084. Epub 2008 Aug 14.

PMID:
18706956
9.

Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.

Ichinohe T, Ainai A, Nakamura T, Akiyama Y, Maeyama J, Odagiri T, Tashiro M, Takahashi H, Sawa H, Tamura S, Chiba J, Kurata T, Sata T, Hasegawa H.

J Med Virol. 2010 Jan;82(1):128-37. doi: 10.1002/jmv.21670.

PMID:
19950232
11.

Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccine.

Wu Q, Xiao S, Fan H, Li Y, Xu J, Li Z, Lu W, Su X, Zou W, Jin M, Chen H, Fang L.

Antiviral Res. 2011 Dec;92(3):493-6. doi: 10.1016/j.antiviral.2011.10.001. Epub 2011 Oct 12.

PMID:
22020305
13.

Evaluation of the efficacy of a pre-pandemic H5N1 vaccine (MG1109) in mouse and ferret models.

Song MS, Moon HJ, Kwon HI, Pascua PN, Lee JH, Baek YH, Woo GJ, Choi J, Lee S, Yoo H, Oh I, Yoon Y, Rho JB, Sung MH, Hong SP, Kim CJ, Choi YK.

J Microbiol. 2012 Jun;50(3):478-88. doi: 10.1007/s12275-012-1573-z. Epub 2012 Jun 30. Erratum in: J Microbiol. 2012 Aug;50(4):715. Woo, Kyu-Jin [corrected to Woo, Gyu-Jin].

PMID:
22752912
14.

Baculovirus as an avian influenza vaccine vector: differential immune responses elicited by different vector forms.

Chen CY, Liu HJ, Tsai CP, Chung CY, Shih YS, Chang PC, Chiu YT, Hu YC.

Vaccine. 2010 Nov 10;28(48):7644-51. doi: 10.1016/j.vaccine.2010.09.048. Epub 2010 Sep 28.

PMID:
20883735
15.

Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine.

Song M, Hong HA, Huang JM, Colenutt C, Khang DD, Nguyen TV, Park SM, Shim BS, Song HH, Cheon IS, Jang JE, Choi JA, Choi YK, Stadler K, Cutting SM.

Vaccine. 2012 May 9;30(22):3266-77. doi: 10.1016/j.vaccine.2012.03.016. Epub 2012 Mar 22.

PMID:
22446640
16.

Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus.

Biesova Z, Miller MA, Schneerson R, Shiloach J, Green KY, Robbins JB, Keith JM.

Vaccine. 2009 Oct 19;27(44):6234-8. doi: 10.1016/j.vaccine.2009.07.107. Epub 2009 Aug 15.

PMID:
19686692
17.

Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages.

Prabakaran M, He F, Meng T, Madhan S, Yunrui T, Jia Q, Kwang J.

J Virol. 2010 Nov;84(22):11822-30. doi: 10.1128/JVI.00891-10. Epub 2010 Sep 15.

18.

Hemagglutinin displayed baculovirus protects against highly pathogenic influenza.

Tang XC, Lu HR, Ross TM.

Vaccine. 2010 Oct 4;28(42):6821-31. doi: 10.1016/j.vaccine.2010.08.040. Epub 2010 Aug 18.

PMID:
20727393
19.

Cross-clade protection against HPAI H5N1 influenza virus challenge in BALB/c mice intranasally administered adjuvant-combined influenza vaccine.

Yang P, Tang C, Luo D, Zhan Z, Xing L, Duan Y, Jia W, Peng D, Liu X, Wang X.

Vet Microbiol. 2010 Nov 20;146(1-2):17-23. doi: 10.1016/j.vetmic.2010.03.024. Epub 2010 Mar 31.

PMID:
20888151
20.

Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules.

Lei H, Xu Y, Chen J, Wei X, Lam DM.

Virology. 2010 Nov 25;407(2):319-24. doi: 10.1016/j.virol.2010.08.007. Epub 2010 Sep 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk